Belgium· BE-AMP-SAM472364-00

Otezla 30 mg

A apremilast product containing apremilast, registered in Belgium by Amgen Europe. The same ATC class is registered in 18 of our 19 countries.

ATC L04AA32

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about apremilastAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Apremilast is registered in 18 of 19 countries.

Countries holding a registration under ATC L04AA32 (apremilast), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search apremilast products by name

Apremilast · ATC L04AA32

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of apremilast costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $13.92 in Switzerland to $51.51 in Italy — a ×3.7 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Apremilast · price per daily dose (60 mg)

USD · FX 28 Sept 2026

IT Italy$51.51
CZ Czechia$51.22
FR France$22.59
CH Switzerland$13.92

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Apremilast
Manufacturer: Amgen Europe
Country: Belgium (BE)
ATC code: L04AA32
ATC class: Apremilast
Defined daily dose: 60 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 3

2 priced

be_apb
4961728
EUR 854.66
be_apb
3314275
EUR 292.19
be_apb
7714736

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for apremilast.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check apremilast against other medicines How interaction checks work

Apremilast · interactions on record

82 records

11 severe
69 moderate
2 minor

Most severe, free to view

RifampicinJ04AB02severe
MitotaneL01XX23severe
EnzalutamideL02BB04severe
ApalutamideL02BB05severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Apremilast in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All apremilast products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Apremilast +pharma, Apremilast Devatis
Bulgaria · Тивлемак
Cyprus · Apremilast Ebewe, Apremilast Sandoz
Czechia · Apremilast +pharma, Apremilast Belupo
Germany · Apremilast, Apremilast 089pharm
Denmark · Apremilast Devatis, Apremilast Stada
Estonia · Apremilast Krka, Apremilast Stada
Spain · Apremilast, Apremilast Aurovitas Spain
Finland · Apremilast Avansor, Apremilast Bioglan
France · Apremilast Arrow, Apremilast Biogaran
United Kingdom (Northern Ireland) · Apremilast, Apremilast Amarox
Greece · Afimax, Apremilast Anabiosis
Croatia · Aperzyx, Apremilast Belupo
Hungary · Apremilast Kezdőcsomag Stada, Apremilast Krka
Ireland · Apremilast 30mg Tablets, Apremilast Aurobindo
Iceland · Apremilast Accord, Apremilast Aristo
Italy · Apremilast Day Zero, Apremilast Dr. Reddy’s
Liechtenstein · Apremilast Accord
Lithuania · Apremilast Krka, Apremilast Stada
Luxembourg · Apremilast Eg
Latvia · Apremilast Krka, Apremilast Stada
Malta · Apremilast, Apremilast Clonmel
Netherlands · Apremilast Amarox, Apremilast Devatis
Norway · Apremilast Accord, Apremilast Devatis
Poland · Apremilast Aristo, Apremilast Farmaprojects
Portugal · Apremilaste Humanis
Romania · Apremilast Stada
Sweden · Apremilast Anabiosis, Apremilast Avansor
Slovenia · Apremilast Belupo, Apremilast Elpen
Slovakia · Apremilast Belupo, Apremilast Hcs

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e463b17e-cb6e-4ff6-bff4-398ac5323c5f
GET /v1/drugs/e463b17e-cb6e-4ff6-bff4-398ac5323c5f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Otezla 30 mg",
  "name_fr": "Otezla 30 mg",
  "name_nl": "Otezla 30 mg",
  "amp_code": "SAM472364-00",
  "strengths": [
    "30.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Apremilast",
    "Lactose Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Apremilast",
  "authorisation_numbers": [
    "EU/1/14/981/003",
    "EU/1/14/981/002"
  ]
}

API reference MCP server Plans

See everything about apremilast.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console